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Purpose of research: Assessing the system of neutrophil elastase (NE) − the
activity and content of antiproteases (anti-NE) in children with congenital bronchial
pathology (CBP), lung pathology (CLP) and cystic ﬁbrosis (CF).
Patients and Methodology: 59 patients, 1−17 years, were studied, all with CB&LP
and CF. Control Group (C) included 10 children with no somatic pathology. The NE
activity was judged by the intensity of division of N-metoxysuccinyl–ALA–ALA–
PRO–VAL–L–Nitroanilide on the DU 530 Beckman spectrometer. The content of
NE and anti-NE was determined by immuno-enzymic method.
Results: The highest NE levels (5 times higher than those in the C) were
demonstrated in patients with CBP; patients with CLP demonstrated somewhat
lesser levels and the CF patients showed still lesser levels. The CF patients’ levels
of NE were 2.5−3 times higher than those in the C (in all cases p< 0.05−0.01).
NE level in groups showing considerable differences in the enzyme content did not
differ much from the C. It was only in patients with CLP that the NE activity was
2 times lower than in the C, while in others it slightly exceeded the C data. The
level of anti-NE in CF patients was 2 times higher than in C and CB&LP.
Conclusion: It was found that the NE amounts and activity in the C was relatively
on the same level. In CBP and CLP patients, the amount of NE was 10 and 5 times
(respectively) higher than the data for the activity of the enzyme, while in the CF
patients, it was only 3 times higher, with the level of anti-NE being 2 times lower
than in other groups, which, evidently, is the reason for overproduction of viscous
bronchial secretion in CF cases.
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Background: It has been shown in broncho-alveolar lavage (BAL) of children
with cystic ﬁbrosis (CF) that TH2 cytokines are elevated. This is especially true
for patients with chronic PA infection. However, it is unclear whether a Th-2 type
proﬁle predisposes for – or is a consequence of PA infection. We investigated
whether children with acute PA infection display a distinct cytokine proﬁle in the
lung.
Methods: The cytokine pattern was assessed in 68 children (32 boys, 36 girls;
median age 6.08 years), 47 children with CF and 21 controls (11 children
following lung transplantation, 10 children with recurrent pulmonary infections).
Bronchoscopy was performed under general aneasthesia and the last aliquot of
standard BAL (3x1ml/kg/bodyweight; NaCl 0.9%) was used for analysis. Cytokines
and chemokines (IL6, -8, -13, -17, IFN-g, TARC) were measured via multiplex
sandwich ELISA. Univariate analysis to investigate differences with regard to age,
sex, PA-infection and correlations with lung function parameters and age were
performed for each cytokine.
Results: CF-patients displayed signiﬁcantly increased IL-6, -8, -13 and 17 levels
in lavage ﬂuid. Cytokine expression did not correlate directly with age or lung
function parameters. PA-infection did not signiﬁcantly impact cytokine expression.
Conclusion: Although cytokine expression was augmented in the CF-group our
data suggest indirectly that children with acute PA infection may not display a
different cytokine proﬁle per se that predisposes to chronic PA. These results need
to be conﬁrmed in a prospective setting.
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Background: Neutrophil elastase (NE) is chronically elevated in cystic ﬁbrosis
(CF) airways. The inhaled antibiotics colistin (C) and tobramycin (T) may affect NE
activity and differentially derange protease-antiprotease balance. Here we directly
compared two currently used antibiotic preparations.
Methods: NE was studied at 8, 4, 2, 1, 0.5 mg/ml in the presence or absence
of protein (0.1% bovine serum albumin (BSA)); C (Colistin CF, Gru¨nenthal) or
T (Tobi, Novartis) were added at concentrations of 1000, 100, 10, 1mM (n= 3).
NE activity was determined over time by elastolytic cleavage of the chromogenic
substrate MSAAP.
Results: NE activity was generally higher in the presence of BSA than in its absence
(p< 0.0001). This suggested loss of NE by binding to reaction tube surfaces. As
in inﬂamed airways many proteins are present, the conditions with BSA may more
closely represent those in CF patients. Both, the addition of C or T reduced NE
activity. With BSA, C inhibited NE by about 25% at 1mM, T 24% to 35% at
1000−10mM compared to controls without antibiotics. Without BSA, C inhibited
NE by 73% at 1mM and T by 70−78% at 1000–100mM (P< 0.05, ANOVA). Similar
effects were observed at the other NE concentrations.
Conclusion: Previously it was suggested that Colistin might augment NE activity.
Here we show that both, Colistin and Tobramycin inhibited NE activity at several
concentrations. The extent of inhibition was dependent on protein concentration
in the assay, being smaller in its presence. These in vitro data suggest that in CF
airways with high concentrations of protein, both C and T may be slightly inhibitory
on NE; clinical studies must verify the signiﬁcance of these ﬁndings in patients.
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Defective CFTR-mediated Cl− secretion plays a central role in the pathogenesis
of cystic ﬁbrosis (CF) lung disease. Functional studies documented that airway
epithelia express alternative Ca2+-activated Cl− channels (CaCC), which have been
proposed as a therapeutic target to compensate for lack of CFTR activity in CF
patients. However, the molecular identity of CaCC has not been unequivocally
identiﬁed. The goal of this study was to determine the role of mClca3 (gob-5) as a
putative candidate for the endogenous CaCC. To determine the role of mClca3
in Ca2+-activated Cl− secretion, we performed transepithelial measurements of
ion transport in freshly excised tracheal tissues from mClca3-deﬁcient mice and
wild-type littermates using perfused Ussing chambers. Further, we performed im-
munohistochemistry and histology to compare mClca3 localization and pulmonary
morphology in mClca3-deﬁcient and wild-type mice. We demonstrate that basal
Cl− secretion (bumetanide-sensitive Isc) and Ca2+-activated Cl− secretion (UTP-
induced Isc) were not altered in mClca3-deﬁcient mice compared to wild-type
controls. Further transepithelial Na+ absorption and cAMP-induced Cl− secretion
were normal in mClca3-deﬁcient mice. Lack of pulmonary expression of mClca3
was conﬁrmed by immunohistochemistry in mClca3 deﬁcient mice, but did not
result in a spontaneous lung disease phenotype. Our results argue against a role for
mClca3 in Ca2+-activated Cl− secretion in the murine lung.
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